The Federal Trade Commission accuses CVS, Cigna and UnitedHealth of artificially inflating prices on specialty generic drugs ...
The FDC released a second highly critical report of PBMs, which may provide further impetus for legislative action to curb ...
The practice inflated costs for consumers and insurers on key treatments for cancer, multiple sclerosis, HIV, organ transplants, and other conditions and procedures, the FTC said. The report ...
Upon closer examination, neither the tragedy nor the widespread vitriol expressed in social media should be surprising. The ...
The Consumer Financial Protection Bureau sued Capital One ( COF +1.89%) on Tuesday for allegedly “cheating” people out of ...
Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...
The health-care sector has been rebounding recently following a sharp selloff in recent weeks amid hopes that controversy would die down. The health-care industry group was among the leading S&P 500 ...
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
The Federal Trade Commission accuses CVS, Cigna and UnitedHealth of artificially inflating prices on specialty generic drugs ...
The nation's three largest pharmacy benefit managers have significantly marked up the prices of certain medicines, including ...
The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...
We recently published a list of 12 Best Safe Dividend Stocks for 2025. In this article, we are going to take a look at where ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback